| Literature DB >> 32551899 |
Tim Flerlage1,2, Aisha Souquette3, E Kaitlynn Allen3, Timothy Brahm3, Jeremy Chase Crawford3, Li Tang4, Yilun Sun4, Gabriela Maron1, Joshua Wolf1,5, Brandon Triplett6, Paul G Thomas3.
Abstract
Allogeneic hematopoietic cell-transplant (alloHCT) recipients are at increased risk of complications from viral respiratory-tract infections (vRTIs). We measured cytokine concentrations in nasal washes (NWs) from pediatric alloHCT recipients to better understand their local response to vRTI. Forty-one immunologic analytes were measured in 70 NWs, collected during and after vRTI, from 15 alloHCT recipients (median age, 11 yr) with 19 episodes of vRTI. These were compared with NW cytokine concentrations from an independent group of otherwise healthy patients. AlloHCT recipients are able to produce a local response to vRTI and produce IFN-α2 and IL-12p40 in significant quantities above an uninfected baseline early in infection. Compared with otherwise healthy comparator-group patients, alloHCT recipients have higher NW concentrations of IL-4 when challenged with vRTI. Further study of these immunologic analytes as well as of type 1 versus type 2 balance in the respiratory mucosa in the context of vRTI during immune reconstitution may be of future research interest in this vulnerable patient population.Entities:
Keywords: allogeneic; cytokines; pediatric; transplant
Mesh:
Substances:
Year: 2020 PMID: 32551899 PMCID: PMC7710331 DOI: 10.1165/rcmb.2020-0014OC
Source DB: PubMed Journal: Am J Respir Cell Mol Biol ISSN: 1044-1549 Impact factor: 6.914